Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

With the stock currently trading at Rs 641.90, Syngene International showcases a moderate uptrend in today's session, amidst ...

BridgeBio Pharma, Inc.'s stock soars on Attruby's launch and licensing deals. Click for more on BBIO growth, competition, and ...

Real-time index price for TSX North American Pref Stock Index (STNU), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

US biotech Tourmaline Bio has reported topline data from a Phase II trial of its lead asset, pacibekitug, in people with chronic kidney disease (CKD) and elevated inflammation levels associated with ...

which tends to hurt stock performance. Compared with category peers, the strategy also had more exposure to the Yield factor in the most recent month. Additionally, this strategy has demonstrated ...